tiprankstipranks
Trending News
More News >
Rayonier Advanced Materials (RYAM)
NYSE:RYAM

Rayonier Advanced Materials (RYAM) AI Stock Analysis

Compare
235 Followers

Top Page

RYAM

Rayonier Advanced Materials

(NYSE:RYAM)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$9.50
▲(1.39% Upside)
Action:ReiteratedDate:03/04/26
The score is held down primarily by weak financial performance (shrinking revenue, severe 2025 loss, and volatile/declining cash flow). Technicals are a meaningful offset with strong upward trend signals, while the earnings-call outlook is mixed—clear improvement goals and pricing progress, but significant execution, volume, and refinancing risks. Valuation contributes little support due to losses and no stated dividend yield.
Positive Factors
Contracted Pricing in Specialties
Having 85% of specialties revenue contracted at material price increases is a durable structural lever: it raises baseline realizations, supports margin recovery as volumes normalize, reduces spot exposure, and materially improves the company's ability to generate cash if demand holds, underpinning multi-quarter recovery plans.
New Product Commercialization
A pipeline of commercializing products and higher‑value pulp and paperboard variants diversifies revenue away from commodity segments. These innovations can capture better end‑market pricing, improve mix and margins, and create lasting differentiation that lessens sensitivity to cyclic oversupply in core commodity businesses.
Improving Leverage Position
Leverage that is elevated but improved versus prior years provides some structural financial flexibility: with debt near parity to equity the company has room to execute a refinance or restructure, which can lower fixed charges and support investment in product commercialization and margin restoration over several quarters.
Negative Factors
Volatile and Weak Cash Generation
Large swings in operating and free cash flow, capped by a steep 2025 drop, reduce the company's ability to fund operations, invest in higher‑margin projects, and service debt without external financing. Persistent cash volatility imposes long‑term constraints on strategic flexibility and capital allocation.
High-Cost Debt and Refinancing Risk
Significant high‑cost debt and a large negative FCF year create structural refinancing risk: if the company cannot secure lower cost financing, elevated fixed charges will persist, eroding any margin gains and limiting sustained investment in product rollouts and operations over the medium term.
Structural Oversupply and Import Competition
Enduring import competition and lingering oversupply in commodity segments structurally depress prices and volumes. Even with pricing actions or trade remedies, restoring durable pricing power is uncertain and may require sustained capacity rationalization or product shifting, limiting margin and revenue recovery prospects.

Rayonier Advanced Materials (RYAM) vs. SPDR S&P 500 ETF (SPY)

Rayonier Advanced Materials Business Overview & Revenue Model

Company DescriptionRayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Canada, Japan, Europe, Latin America, other Asian countries, and internationally. The company operates through High Purity Cellulose, Paperboard, and High-Yield Pulp segments. Its products include cellulose specialties, which are natural polymers that are used as raw materials to manufacture a range of consumer-oriented products, such as liquid crystal displays, impact-resistant plastics, thickeners for food products, pharmaceuticals, cosmetics, cigarette filters, high-tenacity rayon yarn for tires and industrial hoses, food casings, paints, and lacquers. The company also offers commodity products, such as commodity viscose pulp used in woven applications, including rayon textiles for clothing and other fabrics, as well as in non-woven applications comprising baby wipes, cosmetic and personal wipes, industrial wipes, and mattress ticking; and absorbent materials consisting of fluff fibers that are used as an absorbent medium in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and non-woven fabrics. In addition, it provides paperboards for packaging, printing documents, brochures, promotional materials, paperback books or catalog covers, file folders, tags, and tickets; and high-yield pulps to produce paperboard and packaging products, printing and writing papers, and various other paper products. The company was founded in 1926 and is headquartered in Jacksonville, Florida.
How the Company Makes MoneyRayonier Advanced Materials generates revenue through the sale of its cellulose specialties and high-purity cellulose products. The company operates on a business model that focuses on both volume sales and pricing strategies tailored to the demands of various industries. Key revenue streams include contracts with major customers in the textile and chemical industries, where consistent product quality and supply reliability are critical. Additionally, RYAM benefits from strategic partnerships with manufacturers and distributors that enhance its market reach. Factors contributing to its earnings include fluctuations in demand for cellulose-based products, innovations in product applications, and the company’s ability to manage production costs effectively.

Rayonier Advanced Materials Earnings Call Summary

Earnings Call Date:Mar 03, 2026
(Q4-2025)
|
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Neutral
The call balanced clear and actionable management priorities (deliver positive free cash flow in 2026, assert pricing leadership in specialties, improve EBITDA across all businesses) and early operational progress (85% of specialties priced at +18%, product introductions, Tardis recovery actions) against material near-term financial and market challenges (negative $88M FCF in 2025, high-cost debt, expected ~20% volume loss from pricing actions, 15% of specialties unplaced, import and oversupply pressures). While management presented a cohesive plan with measurable levers and upcoming trade-remedy catalysts, the company faces meaningful execution and refinancing risk in the near term, leaving the tone cautiously constructive but uncertain.
Q4-2025 Updates
Positive Updates
Pricing Progress in Cellulose Specialties
85% of the specialties business is arranged at an average price increase of 18% versus 2025; management expects the remaining 15% (still under discussion) to come at an even higher average price increase if secured.
Strong Price Gains in Select Products
Management reported achieving near 20% price increases for ether-grade cellulose in Europe and stated nitration-grade cellulose achieved more than the 18% benchmark due to heightened demand (e.g., propellant customers).
Commitment to Positive Free Cash Flow in 2026
Company priority #1 is to deliver positive free cash flow in 2026 after reporting negative free cash flow of $88 million in 2025, with every group focused on this mission-critical goal.
EBITDA Improvement Across the Portfolio
Management expects every business to improve EBITDA in 2026 relative to 2025, targeting a near-zero EBITDA first quarter but a full-year EBITDA substantially better than 2025 as leadership initiatives take effect.
New Product Commercializations and Portfolio Innovation
Multiple new products under commercialization (examples cited: oil & grease board and foldable freezer board in paperboard; new high-yield pulp product under customer testing), and a broader new-product pipeline intended to offset inflation and drive margin improvement.
Operational Actions on Tardis and Biomaterials
Company is instituting a crisis management team to run the Tardis site harder, which should increase feedstock to the BioNova biomaterials joint venture, boosting ethanol and lignosulfonate sales and supporting growth in biomaterials.
Potential Trade Remedies to Support North American Pricing
Company expects preliminary countervailing duty determinations on subsidized Brazilian imports later in March and preliminary antidumping determinations for Brazil and Norway in May; remedies could stack and help restore North American pricing if enacted.
Paperboard Sequential Improvement
Q4 saw sequential increases in paperboard volumes and prices attributed to new product introductions (freezer board), improved plant productivity/quality (fewer culls), and mix improvement.
Negative Updates
Negative Free Cash Flow and High-Cost Debt
2025 free cash flow was negative $88 million and the company carries significant high-cost debt, which management calls unsustainable and a core near-term risk to be addressed through execution and a planned refi.
Planned Volume Reductions in Specialties
The pricing actions are expected to come with material demand impact — arranged pricing (~18% increase) is paired with an expected volume loss of about 20% versus 2025, creating near-term revenue/volume headwinds.
Unplaced Specialties Business Introducing Uncertainty
Approximately 15% of the specialties business remains unplaced and under negotiation; management notes this tranche will likely require prices materially higher than 18% or will force running assets into lower-value markets.
Competitive and Import Pressure
Significant competitive pressure from lower-cost Chinese CLP producers in Europe and subsidized Brazilian imports in North America has eroded pricing and domestic capacity (industry shutdowns in WA, TN, FL, and Temiscaming closure), limiting reinvestment economics.
Structural Oversupply in Some Commodity Segments
Paperboard and high-yield pulp face lingering oversupply, pressuring volumes and margins; high-yield pulp remains oversupplied though a new product is in trials that may help recovery.
Operational Issues at Tardis and Project Non-Participation
Tardis has had production/raw-material availability challenges affecting biomaterials feedstock; company also announced non-participation in a Georgia energy project, illustrating project execution complexity and near-term operational risks.
Balance Sheet and Refinancing Risk
Management highlighted the need to refinance to reduce interest expense and fixed charges; current capital structure and fixed costs are a constraint on delivering sustained improvement if execution slips.
Company Guidance
Management's guidance focused on returning to positive free cash flow in 2026 after 2025 free cash flow of negative $88 million and addressing high‑cost debt, with 85% of the cellulose specialties book now contracted at an average +18% vs. 2025 (with ~20% expected volume loss vs. 2025) and the remaining 15% likely to require materially higher increases; nitration grades have seen increases above 18%. They expect every business to improve EBITDA versus 2025, to bridge a near‑zero EBITDA first quarter as leadership actions take hold, and to deliver a full‑year EBITDA substantially better than 2025 alongside “solid” positive free cash flow and momentum into 2027. Management also flagged potential upside from trade remedies (countervailing duty preliminaries in March for Brazil and antidumping preliminaries in May for Brazil and Norway) and plans to pursue a refinance to lower interest expense.

Rayonier Advanced Materials Financial Statement Overview

Summary
Financials are under heavy pressure: revenue has weakened materially, profitability deteriorated sharply with a severe 2025 loss and EBITDA margin collapse, and cash generation has become volatile with a steep 2025 free-cash-flow drop. Leverage is manageable but negative returns and shrinking assets limit flexibility.
Income Statement
22
Negative
Revenue has weakened meaningfully, with 2025 down sharply versus 2024 and a multi-year pattern of uneven growth. Profitability is pressured: gross margin remains low and net results have been loss-making in most years, capped by a very large net loss in 2025. While EBITDA margin was solid in 2022–2024, it collapsed in 2025, signaling a major deterioration in operating performance and/or significant charges flowing through earnings.
Balance Sheet
44
Neutral
Leverage is elevated but not extreme for the sector, with debt generally around parity with equity (debt-to-equity near ~0.8–1.6 over the period) and improving versus 2020’s higher leverage. However, returns on equity are negative in recent years, including a very large negative in 2025, which indicates the balance sheet is not currently generating attractive shareholder returns. Assets have also trended down from earlier years, suggesting reduced scale and less balance-sheet flexibility than in prior periods.
Cash Flow
33
Negative
Cash generation has become less reliable. Operating cash flow and free cash flow were strong in parts of the period (notably 2021 and 2024), but 2022 saw negative free cash flow and 2025 showed a steep drop to a low level of positive free cash flow. The large negative free cash flow growth in 2025 highlights volatility and raises reinvestment and liquidity-risk concerns if weak operating conditions persist.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.47B1.63B1.64B1.72B1.41B
Gross Profit119.00M165.58M88.15M123.08M74.72M
EBITDA143.00M173.69M81.32M176.94M121.82M
Net Income-420.00M-39.00M-101.83M-14.92M66.41M
Balance Sheet
Total Assets1.76B2.13B2.18B2.35B2.45B
Cash, Cash Equivalents and Short-Term Investments75.00M125.22M75.77M151.80M291.82M
Total Debt779.00M729.82M777.46M853.13M928.71M
Total Liabilities1.43B1.41B1.44B1.52B1.63B
Stockholders Equity316.56M713.88M746.45M829.31M814.34M
Cash Flow
Free Cash Flow-92.00M95.67M8.60M-69.41M140.01M
Operating Cash Flow24.00M203.61M136.27M68.81M233.22M
Investing Cash Flow-114.00M-107.94M-127.28M-94.17M85.39M
Financing Cash Flow30.00M-42.48M-86.95M-73.11M-156.66M

Rayonier Advanced Materials Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.37
Price Trends
50DMA
8.94
Positive
100DMA
7.57
Positive
200DMA
6.45
Positive
Market Momentum
MACD
0.75
Positive
RSI
54.15
Neutral
STOCH
49.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAM, the sentiment is Positive. The current price of 9.37 is below the 20-day moving average (MA) of 10.24, above the 50-day MA of 8.94, and above the 200-day MA of 6.45, indicating a bullish trend. The MACD of 0.75 indicates Positive momentum. The RSI at 54.15 is Neutral, neither overbought nor oversold. The STOCH value of 49.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RYAM.

Rayonier Advanced Materials Risk Analysis

Rayonier Advanced Materials disclosed 29 risk factors in its most recent earnings report. Rayonier Advanced Materials reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Rayonier Advanced Materials Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$1.05B25.00-0.13%12.49%95.48%
64
Neutral
$544.18M9.446.06%3.81%-5.05%35.01%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
52
Neutral
$696.86M-0.94-99.73%-9.75%-386.63%
51
Neutral
$1.11B-1.41-29.85%8.27%-7.81%-334.15%
46
Neutral
$138.61M-2.83-28.62%7.12%-49.82%-195.74%
40
Underperform
$14.85M-1.18-21.95%-28.47%16.83%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RYAM
Rayonier Advanced Materials
10.40
4.91
89.44%
FF
Futurefuel
3.16
-0.74
-18.97%
LXU
Lsb Industries
14.66
7.76
112.46%
TROX
TRONOX
7.01
0.08
1.15%
ASIX
AdvanSix
20.25
-2.02
-9.08%
ORGN
Origin Materials
2.87
-19.15
-86.97%

Rayonier Advanced Materials Corporate Events

Business Operations and Strategy
Rayonier Advanced Materials Withdraws From Altamaha Energy Project
Negative
Jan 26, 2026

On January 26, 2026, Rayonier Advanced Materials Inc. announced that, following a comprehensive review, it has decided not to move forward with its participation in the Altamaha Green Energy project, signaling a strategic pullback from this specific initiative. The company stated it will continue to assess its project portfolio under a disciplined capital allocation framework, indicating an ongoing focus on prioritizing investments that align more tightly with its strategic and financial objectives, with potential implications for how it deploys capital across future growth and sustainability-related opportunities.

The most recent analyst rating on (RYAM) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Rayonier Advanced Materials stock, see the RYAM Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Rayonier Advanced Materials consolidates leadership after SVP departure
Neutral
Jan 12, 2026

On January 11, 2026, Rayonier Advanced Materials Inc. announced the separation of Joshua Hicks, its Senior Vice President of High Purity Cellulose, effective the same day, marking a leadership change within its key high-purity cellulose segment. Following his departure, the High Purity Cellulose organization will report directly to President and Chief Executive Officer Scott Sutton, signaling a consolidation of oversight at the top executive level that may streamline decision-making and operational alignment within this strategic business unit.

The most recent analyst rating on (RYAM) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Rayonier Advanced Materials stock, see the RYAM Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Rayonier Advanced Materials CEO Announces Retirement Plan
Neutral
Dec 10, 2025

On December 10, 2025, Rayonier Advanced Materials announced that its President and CEO, De Lyle W. Bloomquist, will retire by the company’s 2026 Annual Meeting of Stockholders in May. The Board has initiated a search for his successor, engaging a leading executive search firm, reflecting their commitment to governance and long-term value creation. Bloomquist’s leadership over the past four years has been pivotal in advancing the company’s BioFuture vision and positioning it for sustainable growth.

The most recent analyst rating on (RYAM) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Rayonier Advanced Materials stock, see the RYAM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 04, 2026